Maria Angeles Ceregido

机构：GlaxoSmithKline (Belgium) · ORCID：0009-0004-5412-2641

发表论文 28 篇 · 总被引 746 次 · h-index 15

代表论文

• A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis (2020 · Expert Review of Vaccines · 被引 137)
• Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial (2022 · EClinicalMedicine · 被引 106)
• Adjuvant system AS01: from mode of action to effective vaccines (2024 · Expert Review of Vaccines · 被引 96)
• Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities (2022 · npj Vaccines · 被引 39)
• Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial (2019 · Vaccine · 被引 39)
• Phase 2 Randomized Trial of an AS03 Adjuvanted Plant-Based Virus-Like Particle Vaccine for Covid-19 in Healthy Adults, Older Adults and Adults with Comorbidities (2021 · medRxiv · 被引 35)